Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 83 entries
Sorted by: Best Match Show Resources per page
Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine.

Redox report : communications in free radical research

Wasil M, Kelly FJ.
PMID: 27405835
Redox Rep. 1995 Nov;1(5):361-7. doi: 10.1080/13510002.1995.11747012.

The angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine, protect myocardial tissue from ischaemia/reperfusion-induced injury. Although both drugs have well established, independent mechanisms of cardiac protection, they may also have antioxidant activity which could contribute to their...

Cite
Wasil M, Kelly FJ. Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine. Redox Rep. 1995;1(5):361-7doi: 10.1080/13510002.1995.11747012.
Wasil, M., & Kelly, F. J. (1995). Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine. Redox report : communications in free radical research, 1(5), 361-7. https://doi.org/10.1080/13510002.1995.11747012
Wasil, M, and Kelly, F J. "Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine." Redox report : communications in free radical research vol. 1,5 (1995): 361-7. doi: https://doi.org/10.1080/13510002.1995.11747012
Wasil M, Kelly FJ. Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine. Redox Rep. 1995 Nov;1(5):361-7. doi: 10.1080/13510002.1995.11747012. PMID: 27405835.
Copy Download .nbib Format: NLM
[Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency-of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease].

Kardiologiia

Sizova ZM, Kozlova NV, Zakharova VL, Shameeva ES.
PMID: 28294804
Kardiologiia. 2015 Feb;55(2):10-15.

AIM: to compare effects of isosorbide dinitrate, isosorbide-5-mononitrate and nicorandil on frequency of angina attacks and vasoregulating endothelial function in patients with ischemic heart disease (IHD).MATERIAL AND METHODS: In 117 patients with stable II-III functional class angina we analyzed...

Cite
Sizova ZM, Kozlova NV, Zakharova VL, et al. [Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency-of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease]. Kardiologiia. 2015;55(2):10-15
Sizova, Z. M., Kozlova, N. V., Zakharova, V. L., & Shameeva, E. S. (2015). [Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency-of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease]. Kardiologiia, 55(2), 10-15.
Sizova, Z M, et al. "[Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency-of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease]." Kardiologiia vol. 55,2 (2015): 10-15.
Sizova ZM, Kozlova NV, Zakharova VL, Shameeva ES. [Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency-of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease]. Kardiologiia. 2015 Feb;55(2):10-15. Russian. PMID: 28294804.
Copy Download .nbib Format: NLM
Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil.

American health & drug benefits

Hawkins-Taylor C, Carlson AM.
PMID: 24991371
Am Health Drug Benefits. 2013 Sep;6(7):401-12.

BACKGROUND: The American population's diversity continues to grow, and its racial and ethnic mixes are changing. The US healthcare system must confront this changing reality. The introduction of isosorbide dinitrate/hydralazine hydrochloride (BiDil) to the US marketplace was a move...

Cite
Hawkins-Taylor C, Carlson AM. Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil. Am Health Drug Benefits. 2013;6(7):401-12
Hawkins-Taylor, C., & Carlson, A. M. (2013). Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil. American health & drug benefits, 6(7), 401-12.
Hawkins-Taylor, Chamika, and Carlson, Angeline M. "Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil." American health & drug benefits vol. 6,7 (2013): 401-12.
Hawkins-Taylor C, Carlson AM. Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil. Am Health Drug Benefits. 2013 Sep;6(7):401-12. PMID: 24991371; PMCID: PMC4031729.
Copy Download .nbib Format: NLM
Nitrate-Induced Headache in Patients with Stable Angina Pectoris: Beneficial Effect of Starting on a Low Dosage.

American journal of therapeutics

Cleophas TJ, Niemeyer MG, van Der Wall EE.
PMID: 11862241
Am J Ther. 1996 Dec;3(12):802-806. doi: 10.1097/00045391-199612000-00003.

BACKGROUND: Nitrates, although important for the management of angina pectoris, cause significant headache in many patients. METHODS: In a randomized, double-blind crossover study, 89 patients with stable angina pectoris were used to compare two different dosage strategies of isosorbide-5-mononitrate...

Cite
Cleophas TJ, Niemeyer MG, van Der Wall EE. Nitrate-Induced Headache in Patients with Stable Angina Pectoris: Beneficial Effect of Starting on a Low Dosage. Am J Ther. 1996;3(12):802-806doi: 10.1097/00045391-199612000-00003.
Cleophas, T. J., Niemeyer, M. G., & van Der Wall, E. E. (1996). Nitrate-Induced Headache in Patients with Stable Angina Pectoris: Beneficial Effect of Starting on a Low Dosage. American journal of therapeutics, 3(12), 802-806. https://doi.org/10.1097/00045391-199612000-00003
Cleophas, Ton J.M., et al. "Nitrate-Induced Headache in Patients with Stable Angina Pectoris: Beneficial Effect of Starting on a Low Dosage." American journal of therapeutics vol. 3,12 (1996): 802-806. doi: https://doi.org/10.1097/00045391-199612000-00003
Cleophas TJ, Niemeyer MG, van Der Wall EE. Nitrate-Induced Headache in Patients with Stable Angina Pectoris: Beneficial Effect of Starting on a Low Dosage. Am J Ther. 1996 Dec;3(12):802-806. doi: 10.1097/00045391-199612000-00003. PMID: 11862241.
Copy Download .nbib Format: NLM
Coronary Artery Spasm.

Current treatment options in cardiovascular medicine

Lanza GA, Maseri A.
PMID: 11096513
Curr Treat Options Cardiovasc Med. 2000 Feb;2(1):83-90. doi: 10.1007/s11936-000-0031-0.

Attacks of variant angina usually respond promptly to sublingual administration of short-acting nitrates (nitroglycerin, 0.3 to 0.4 mg, or isosorbide dinitrate, 5 to 10 mg), which may be repeated after 3 to 5 minutes if pain persists. In the...

Cite
Lanza GA, Maseri A. Coronary Artery Spasm. Curr Treat Options Cardiovasc Med. 2000;2(1):83-90doi: 10.1007/s11936-000-0031-0.
Lanza, G. A., & Maseri, A. (2000). Coronary Artery Spasm. Current treatment options in cardiovascular medicine, 2(1), 83-90. https://doi.org/10.1007/s11936-000-0031-0
Lanza, and Maseri. "Coronary Artery Spasm." Current treatment options in cardiovascular medicine vol. 2,1 (2000): 83-90. doi: https://doi.org/10.1007/s11936-000-0031-0
Lanza GA, Maseri A. Coronary Artery Spasm. Curr Treat Options Cardiovasc Med. 2000 Feb;2(1):83-90. doi: 10.1007/s11936-000-0031-0. PMID: 11096513.
Copy Download .nbib Format: NLM
Treatment of Older Patients With CHF Associated With Normal LVEF.

The American journal of geriatric cardiology

Aronow WS.
PMID: 11416478
Am J Geriatr Cardiol. 1998 Nov;7(6):27-31.

CHF with a normal LVEF should be treated with a low salt diet, cautious use of loop diuretics, and à -blockers. If CHF persists despite the use of diuretics and à -blockers, ACE inhibitors should be administered. If the...

Cite
Aronow WS. Treatment of Older Patients With CHF Associated With Normal LVEF. Am J Geriatr Cardiol. 1998;7(6):27-31
Aronow, W. S. (1998). Treatment of Older Patients With CHF Associated With Normal LVEF. The American journal of geriatric cardiology, 7(6), 27-31.
Aronow, Wilbert S.. "Treatment of Older Patients With CHF Associated With Normal LVEF." The American journal of geriatric cardiology vol. 7,6 (1998): 27-31.
Aronow WS. Treatment of Older Patients With CHF Associated With Normal LVEF. Am J Geriatr Cardiol. 1998 Nov;7(6):27-31. PMID: 11416478.
Copy Download .nbib Format: NLM
Determination of isosorbide dinitrate in arterial plasma, synthetic serum and pharmaceutical formulations by linear sweep voltammetry on a gold electrode.

Talanta

Parham H, Zargar B.
PMID: 18968368
Talanta. 2001 Aug 30;55(2):255-62. doi: 10.1016/s0039-9140(01)00416-7.

Isosorbide dinitrate (ISDN) is reduced voltammetrically at gold working electrode surface in aqueous sodium sulfite solution and produces a voltammogram with its peak current proportional to the concentration of ISDN in the range of 1.3-2340 mug ml(-1). Sodium sulfite...

Cite
Parham H, Zargar B. Determination of isosorbide dinitrate in arterial plasma, synthetic serum and pharmaceutical formulations by linear sweep voltammetry on a gold electrode. Talanta. 2001;55(2):255-62doi: 10.1016/s0039-9140(01)00416-7.
Parham, H., & Zargar, B. (2001). Determination of isosorbide dinitrate in arterial plasma, synthetic serum and pharmaceutical formulations by linear sweep voltammetry on a gold electrode. Talanta, 55(2), 255-62. https://doi.org/10.1016/s0039-9140(01)00416-7
Parham, H, and Zargar, B. "Determination of isosorbide dinitrate in arterial plasma, synthetic serum and pharmaceutical formulations by linear sweep voltammetry on a gold electrode." Talanta vol. 55,2 (2001): 255-62. doi: https://doi.org/10.1016/s0039-9140(01)00416-7
Parham H, Zargar B. Determination of isosorbide dinitrate in arterial plasma, synthetic serum and pharmaceutical formulations by linear sweep voltammetry on a gold electrode. Talanta. 2001 Aug 30;55(2):255-62. doi: 10.1016/s0039-9140(01)00416-7. PMID: 18968368.
Copy Download .nbib Format: NLM
The African-American heart failure trial: a new look at old drugs.

Future cardiology

Felker GM.
PMID: 19804113
Future Cardiol. 2005 May;1(3):311-3. doi: 10.1517/14796678.1.3.311.

Evaluation of: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. Taylor AL, Zieche S, Yancy C et al.: N. Engl. J. Med. 351, 2049-2057 (2004). The African-American Heart Failure Trial (AHeFT) evaluated the efficacy of a...

Cite
Felker GM. The African-American heart failure trial: a new look at old drugs. Future Cardiol. 2005;1(3):311-3doi: 10.1517/14796678.1.3.311.
Felker, G. M. (2005). The African-American heart failure trial: a new look at old drugs. Future cardiology, 1(3), 311-3. https://doi.org/10.1517/14796678.1.3.311
Felker, G Michael. "The African-American heart failure trial: a new look at old drugs." Future cardiology vol. 1,3 (2005): 311-3. doi: https://doi.org/10.1517/14796678.1.3.311
Felker GM. The African-American heart failure trial: a new look at old drugs. Future Cardiol. 2005 May;1(3):311-3. doi: 10.1517/14796678.1.3.311. PMID: 19804113.
Copy Download .nbib Format: NLM
Topical nitrate drip infusion using cystic duct tube for retained bile duct stone: A six patients case series.

World journal of gastrointestinal surgery

Shoji M, Sakuma H, Yoshimitsu Y, Maeda T, Nakai M, Ueda H.
PMID: 23805368
World J Gastrointest Surg. 2013 Jun 27;5(6):210-5. doi: 10.4240/wjgs.v5.i6.210.

A retained bile duct stone after operation for cholelithiasis still occurs and causes symptoms such as biliary colic and obstructive jaundice. An endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy (EST), followed by stone extraction, are usually an effective treatment for...

Cite
Shoji M, Sakuma H, Yoshimitsu Y, et al. Topical nitrate drip infusion using cystic duct tube for retained bile duct stone: A six patients case series. World J Gastrointest Surg. 2013;5(6):210-5doi: 10.4240/wjgs.v5.i6.210.
Shoji, M., Sakuma, H., Yoshimitsu, Y., Maeda, T., Nakai, M., & Ueda, H. (2013). Topical nitrate drip infusion using cystic duct tube for retained bile duct stone: A six patients case series. World journal of gastrointestinal surgery, 5(6), 210-5. https://doi.org/10.4240/wjgs.v5.i6.210
Shoji, Masatoshi, et al. "Topical nitrate drip infusion using cystic duct tube for retained bile duct stone: A six patients case series." World journal of gastrointestinal surgery vol. 5,6 (2013): 210-5. doi: https://doi.org/10.4240/wjgs.v5.i6.210
Shoji M, Sakuma H, Yoshimitsu Y, Maeda T, Nakai M, Ueda H. Topical nitrate drip infusion using cystic duct tube for retained bile duct stone: A six patients case series. World J Gastrointest Surg. 2013 Jun 27;5(6):210-5. doi: 10.4240/wjgs.v5.i6.210. PMID: 23805368; PMCID: PMC3692960.
Copy Download .nbib Format: NLM
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women.

International journal of pharmaceutical compounding

Mason D.
PMID: 23979300
Int J Pharm Compd. 2002 Jul-Aug;6(4):255-6.

No abstract available.

Cite
Mason D. Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women. Int J Pharm Compd. 2002;6(4):255-6
Mason, D. (2002). Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women. International journal of pharmaceutical compounding, 6(4), 255-6.
Mason, David. "Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women." International journal of pharmaceutical compounding vol. 6,4 (2002): 255-6.
Mason D. Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women. Int J Pharm Compd. 2002 Jul-Aug;6(4):255-6. PMID: 23979300.
Copy Download .nbib Format: NLM
Fatal Multi-Vessel Coronary Vasospasm: A Case Report.

Cureus

Aissaoui H, Boutaybi M, Ikbal A, Elouafi N, Ismaili N.
PMID: 32596087
Cureus. 2020 May 25;12(5):e8271. doi: 10.7759/cureus.8271.

We report a case of a 59-year-old female who experienced a history of an acute ST myocardial infarction. Percutaneous intervention and isosorbide dinitrate perfusion were successful in reversing the severe vasospasm on the left anterior descending, the first diagonal,...

Cite
Aissaoui H, Boutaybi M, Ikbal A, et al. Fatal Multi-Vessel Coronary Vasospasm: A Case Report. Cureus. 2020;12(5):e8271doi: 10.7759/cureus.8271.
Aissaoui, H., Boutaybi, M., Ikbal, A., Elouafi, N., & Ismaili, N. (2020). Fatal Multi-Vessel Coronary Vasospasm: A Case Report. Cureus, 12(5), e8271. https://doi.org/10.7759/cureus.8271
Aissaoui, Hanane, et al. "Fatal Multi-Vessel Coronary Vasospasm: A Case Report." Cureus vol. 12,5 (2020): e8271. doi: https://doi.org/10.7759/cureus.8271
Aissaoui H, Boutaybi M, Ikbal A, Elouafi N, Ismaili N. Fatal Multi-Vessel Coronary Vasospasm: A Case Report. Cureus. 2020 May 25;12(5):e8271. doi: 10.7759/cureus.8271. PMID: 32596087; PMCID: PMC7314376.
Copy Download .nbib Format: NLM
Effect of isosorbide dinitrate on non-cirrhotic portal hypertension.

The National medical journal of India

Roy DG, Kaur U, Chawla YK, Singh K, Dilawari JB.
PMID: 29751471
Natl Med J India. 1991 Jan-Feb;4(1):5-9.

Among the many drugs including propranolol that have been evaluated for the pharmacological control of portal hypertension, isosorbide dinitrate (ISDN) fulfils the criteria of patient acceptability, ease of administration and production of the desired effect. Forty-three consecutive patients with...

Cite
Roy DG, Kaur U, Chawla YK, et al. Effect of isosorbide dinitrate on non-cirrhotic portal hypertension. Natl Med J India. 1991;4(1):5-9
Roy, D. G., Kaur, U., Chawla, Y. K., Singh, K., & Dilawari, J. B. (1991). Effect of isosorbide dinitrate on non-cirrhotic portal hypertension. The National medical journal of India, 4(1), 5-9.
Roy, D Ghosh, et al. "Effect of isosorbide dinitrate on non-cirrhotic portal hypertension." The National medical journal of India vol. 4,1 (1991): 5-9.
Roy DG, Kaur U, Chawla YK, Singh K, Dilawari JB. Effect of isosorbide dinitrate on non-cirrhotic portal hypertension. Natl Med J India. 1991 Jan-Feb;4(1):5-9. PMID: 29751471.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 83 entries